
P&G's $3.8 Billion Thorne Deal Shows Where Beauty Is Heading Next
Announced on 4 August 2026, Procter & Gamble's all-cash purchase of supplements maker Thorne signals the beauty-wellness convergence reaching big pharma-adjacent prices.
Beauty News reports what changes on the shelf: launches, reformulations made without announcement, discontinued shades, recalls and rulings on ingredients. Items note whether an earlier Beauty Ring verdict still holds after the change. Meant for readers who repurchase the same products and dislike surprises.

Announced on 4 August 2026, Procter & Gamble's all-cash purchase of supplements maker Thorne signals the beauty-wellness convergence reaching big pharma-adjacent prices.

Announced on 7 July 2026, Coty agreed to return the Gucci Beauty license to Kering for about $400 million, clearing the way for L'Oréal's 50-year deal.

Regulator-confirmed recalls are sweeping Australian sunscreen after independent testing found 16 of 20 products fell short of their claimed SPF.

On 21 May 2026, Estée Lauder and Puig terminated discussions about a potential combination, and Estée Lauder shares jumped double digits.

On 4 May 2026, FDA posted an update on implementing MoCRA, the 2022 law that gave the agency real authority over cosmetics for the first time.

Confirmed on 23 March 2026, merger discussions between Estée Lauder and Spain's Puig could build a beauty group worth around $40 billion.